• Investing
  • Stock
  • Editor’s Pick
  • Economy
The Significant Deals
Stock

Indonesia e-commerce firm Bukalapak to stop selling physical goods as competition mounts

by January 8, 2025
written by January 8, 2025

JAKARTA (Reuters) – Indonesian e-commerce firm Bukalapak said on Tuesday that it would stop selling physical items on its marketplace soon, amid tough competition from TikTok’s Tokopedia and Sea’s Shopee in Southeast Asia’s largest economy.

Bukalapak, which went public in 2021, said in a statement that it later would only sell virtual products ranging from mobile phone credits to streaming vouchers. Customers have until Feb. 9 to make last orders for certain items, Bukalapak added.

“Bukalapak will undergo a transformation in an effort to increase focus on virtual products … we fully understand that these changes will impact the sellers and we are committed to making this transition as smooth as possible,” the company said.

Shares of Bukalapak were down 4.1% to 117 rupiah on Wednesday as of 0519 GMT.

On the day of its market debut in August 2021, Bukalapak shares had soared by the daily limit of 25% to 1,060 rupiah a piece as investors looked to get a piece of the company that raised $1.5 billion in its initial public offering.

But over the three years since its listing, Bukalapak has faced fierce competition from Indonesia’s e-commerce market leader Shopee, which is owned by Southeast Asian technology firm Sea, and from Tokopedia.

Tokopedia, another homegrown e-commerce company, is now majority owned by ByteDance’s TikTok, which acquired 75.01% of the shares from local tech conglomerate GoTo early last year.

Bukalapak reported a loss of 593.23 billion rupiah ($36.62 million) in the first nine months of 2024, according to its latest financial results.

($1 = 16,200.0000 rupiah)

This post appeared first on investing.com
0 comment
0
FacebookTwitterPinterestEmail

previous post
Taiwan stocks higher at close of trade; Taiwan Weighted up 0.44%
next post
Roche to complete $1.5 billion acquisition of U.S. biopharma company Poseida

You may also like

BASF results down on impairments, restructuring

January 27, 2025

European chipmakers slump as traders gauge DeepSeek AI...

January 27, 2025

Nasdaq futures tumble as China’s AI push rattles...

January 27, 2025

China Vanke’s CEO, chairman resign amid growing liquidity...

January 27, 2025

Fuji Media, rocked by sexual misconduct allegations, says...

January 27, 2025

Italy’s MPS shares fall ahead of Mediobanca board...

January 27, 2025

British Land stock drops following stake sale

January 27, 2025

UMG shares rally after new multi-year pact with...

January 27, 2025

BASF shares indicated 3% lower as impairments drag...

January 27, 2025

Ryanair cuts 2026 traffic forecast amid ongoing Boeing...

January 27, 2025
Sign up and get the scoop before anyone else—fresh updates, and secret deals, all wrapped up just for you. We're talking juicy tips, fun surprises, and invites to events you actually want to go to. Don’t just watch from the sidelines—jump in and be part of the magic!








    By signing up, you're cool with getting emails from us. Don’t worry — your info stays safe, sound, and strictly confidential. No spam, no funny business. Just the good stuff.

    Recent Posts

    • Elon Musk’s SpaceX acquires xAI

      February 25, 2026
    • The architect of Amazon’s supply chain on running a startup with your spouse

      February 25, 2026
    • Trump administration alleges Nike discriminated against white workers

      February 25, 2026
    • Landmark trial accusing social media companies of addicting children to their platforms begins

      February 25, 2026

    Categories

    • Economy (245)
    • Editor's Pick (3,646)
    • Investing (688)
    • Stock (6,426)

    Latest News

    • Elon Musk’s SpaceX acquires xAI
    • The architect of Amazon’s supply chain on running a startup with your spouse

    Popular News

    • Fed’s Goolsbee: Latest jobs report “superb”; more rate cuts ahead
    • Turkey stocks lower at close of trade; BIST 100 down 0.95%

    About The Significant deals

    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2026 thesignificantdeals.com | All Rights Reserved

    The Significant Deals
    • Investing
    • Stock
    • Editor’s Pick
    • Economy